Erik Spaepen

1.3k total citations
56 papers, 981 citations indexed

About

Erik Spaepen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Erik Spaepen has authored 56 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 8 papers in Genetics. Recurrent topics in Erik Spaepen's work include Diabetes Management and Research (27 papers), Diabetes Treatment and Management (17 papers) and Diabetes Management and Education (12 papers). Erik Spaepen is often cited by papers focused on Diabetes Management and Research (27 papers), Diabetes Treatment and Management (17 papers) and Diabetes Management and Education (12 papers). Erik Spaepen collaborates with scholars based in United States, United Kingdom and Belgium. Erik Spaepen's co-authors include Lieven Annemans, Thomas Gilbert, G. Nuki, M. Gaskin, Mireille Bonnemaire, Carine Michiels, Gregor Theilmeier, Ingrid Vreys, D Collen and Jos Vermylen and has published in prestigious journals such as Blood, PLoS ONE and Diabetes.

In The Last Decade

Erik Spaepen

49 papers receiving 944 citations

Peers

Countries citing papers authored by Erik Spaepen

Since Specialization

Citations

This map shows the geographic impact of Erik Spaepen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Spaepen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Spaepen more than expected).

Fields of papers citing papers by Erik Spaepen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Spaepen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Spaepen. The network helps show where Erik Spaepen may publish in the future.

Co-authorship network of co-authors of Erik Spaepen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Spaepen. A scholar is included among the top collaborators of Erik Spaepen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Spaepen. Erik Spaepen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study	Advances in Therapy	Marc Evans, Laurienne Edgar et al.	2
2	Understanding Suboptimal Insulin Use in Type 1 and Type 2 Diabetes: A Cross-Sectional Survey of People with Diabetes	Patient Preference and Adherence	Rachel S. Newson, Esther Artime et al.	0
3	The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective	Patient Preference and Adherence	Virginia Bellido, Natalia Duque et al.	0
4	Which people with diabetes are treated with a disposable, half‐unit insulin pen? A real‐world, retrospective, database study in Spain	Endocrinology Diabetes & Metabolism	Francisco Javier Ampudia‐Blasco, Natalia Duque et al.	1
5	Barriers and solutions for the management of severe hypoglycaemia in people with diabetes in Spain: A Delphi survey	Primary care diabetes	Domingo Orozco‐Beltrán, Adriana López‐Pineda et al.	1
6	POSB372 Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Diabetes Patients in the UK and US	Value in Health	Sebastian Heidenreich, Erik Spaepen et al.	1
7	Nasal Glucagon Is Easier to Use and More Preferred and Needs Less Effort to Administer Than Injectable Glucagon: User Perceptions of Glucagon Administration During Severe Hypoglycemia Simulation	Endocrine Practice	Deborah Hinnen, Erik Spaepen et al.	4
8	Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period	CardioVascular and Interventional Radiology	Tiago Bilhim, Nuno Vasco Costa et al.	48
9	Conversations and Reactions Around Severe Hypoglycemia (CRASH): Japan Results From a Global Survey of People with T1DM or Insulin-Treated T2DM and Caregivers	Diabetes Therapy	Toshiyuki Iwahori, Frank J. Snoek et al.	4
10	Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes	Patient	Sebastian Heidenreich, Jiat Ling Poon et al.	8
11	Successful Revascularization has a Significant Impact on Limb Salvage Rate and Wound Healing for Patients with Diabetic Foot Ulcers: Single-Centre Retrospective Analysis with a Multidisciplinary Approach	CardioVascular and Interventional Radiology	Filipe Veloso Gomes, Nuno Vasco Costa et al.	19
12	An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany	Postgraduate Medicine	Jieling Chen, Magaly Perez‐Nieves et al.	0
13	Fasting experience of patients with Type 2 diabetes mellitus on insulin therapy during Ramadan: VISION Ramadan substudy	Diabetes Research and Clinical Practice	Abdul Jabbar, Wan Mohd Izani Wan Mohamed et al.	7
14	Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region	Diabetes Research and Clinical Practice	Abdul Jabbar, Ahmed Hassoun et al.	21
15	Should Proximal LAD be treated differently? Insights from a large DES stent registry	Cardiovascular revascularization medicine	Arthur Kerner, Eitan Abergel et al.	8
16	PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH	Value in Health	Erik Spaepen, Mark Lamotte et al.	2
17	Health economic consequences related to the diagnosis of fibromyalgia syndrome	PubMed	Lieven Annemans, Simon Wessely et al.	104
18	Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium	Journal of Medical Economics	Lieven Annemans, Vanessa Rémy et al.	33
19	Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000â€“2005	Annals of the Rheumatic Diseases	Lieven Annemans, Erik Spaepen et al.	373
20	Economic impact of hospital malnutrition	Ghent University Academic Bibliography (Ghent University)	Olivier Ethgen, Erik Spaepen et al.	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact